Article
Gene therapy access: Global challenges, opportunities, and views from Brazil, South Africa, and India
4 Apr 2022
Abstract excerpt
Gene and cell therapies for a variety of life-limiting illnesses are under investigation, and a small number of commercial products have successfully obtained regulatory approval. The cost of treatment is high, and clinical studies evaluating safety and efficacy are performed predominately in high-income countries. We reviewed the current status of gene and cell therapies in low- and middle-income countries and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
